CA2390791C - Material delivery device having a plurality of reservoirs and a frusto conical metering member - Google Patents
Material delivery device having a plurality of reservoirs and a frusto conical metering member Download PDFInfo
- Publication number
- CA2390791C CA2390791C CA002390791A CA2390791A CA2390791C CA 2390791 C CA2390791 C CA 2390791C CA 002390791 A CA002390791 A CA 002390791A CA 2390791 A CA2390791 A CA 2390791A CA 2390791 C CA2390791 C CA 2390791C
- Authority
- CA
- Canada
- Prior art keywords
- delivery device
- medicament
- metering member
- inhaler
- measuring cups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0003—Details of inhalators; Constructional features thereof with means for dispensing more than one drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Abstract
There is described a delivery device which comprises a reservoir, a delivery passage for the delivery of material and a metering member characterised in that the delivery device is provided with a plurality of reservoirs and that the metering member is provided with a plurality of measuring cups adapted to transfer one or more measured doses of material from one or more of the reservoirs to the delivery passage. A method of administering a dry powder and a method and especially a method of treatment of a patient with a bronchial disorder are also described.
Description
MATERIAL DELIVERY DEVICE HAVING A PLURALITY OF
RESERVOIRS AND A FRUSTO CONICAL METERING MEMBER
This invention relates to a novel fonn of material delivery device, for example, a medicament delivery device, such as an inhaler. In particular the invention provides a novel form of dry powder inhaler and a method of delivering a medicament.
Dry powder inhalers are known, such as CLICKHALER, produced by Innovata Biomed in the UK. Such a device is described in European Patent No 0 539 469.
Increasingly, patients are required to take more than one medicine and this is no less the case in the treatment of bronchial disorders. Thus, for example, combination therapies such as a steroid with a(32 agonist, e.g. fluticasone and salmeterol, have been commercially successful. To date, the administration of such combination therapies comprises the use of a predetermined formulation either as a dry powder, e.g. in a gelatin capsule, or an aerosol. However, this approach suffers from the disadvantage, inter alia, that the medical practitioner is restricted in that it is not possible to vary the quantities of the two medicaments administered. Thus, there has therefore been a long felt need for a dry powder inhalation system which permits the administration of combination therapies.
We have now developed a novel form of medicament delivery device that overcomes or mitigates this problem.
According to the invention we provide a delivery device which comprises a reservoir, a delivery passage for the delivery of material and a metering member characterised in that the delivery device is provided with a plurality of reservoirs and that the metering member is a frusto conical member provided with a plurality of measuring cups adapted to transfer one or more measured doses of material from one or more of the reservoirs to the delivery passage.
The device of the invention has utility in a variety of areas, including, for example, medicament delivery. Thus, it is especially suited as an inhaler and especially a dry powder inhaler (DPI).
It is within the scope of this invention for more than two medicaments to be administered, however, it is considered most likely that dual combination therapies would be preferred by the medical profession. Thus the description hereinafter will generally refer to a medicament delivery device adapted to administer a dual combination medicarnent, but it would be well understood by one skilled in the art that these references could be construed to multiple combinations.
Thus the medicament reservoir preferentially comprises a dual reservoir, the dual reservoir may, for example, comprise a pair of chimneys. Preferentially, each of the reservoirs is a bulk reservoir which supplies a plurality of doses measured by the metering member. The dimensions of the reservoirs may be the same or different depending, inter alia, upon the respective amounts of medicament it is intended to administer. It is important that the two reservoirs are isolated from one another in order to prevent cross contamination of one medicament with the other.
When the delivery device comprises an inhaler, it is preferentially a dry powder inhaler. An example of a conventional inhaler is a CLICKHALER (available from IB) which is provided with a single inhalation passage. However, in the combination therapy inhaler of the invention, the device may be provided with a single or with two inhalation passages.
Thus according to a preferred embodiment of the invention we provide an inhaler which comprises a medicament reservoir, an inhalation passage for the delivery of medicament and a metering member characterised in that the inhaler is provided with a plurality of inedicament reservoirs and the metering member is provided with a plurality of measuring cups adapted to transfer one or more measured doses of
RESERVOIRS AND A FRUSTO CONICAL METERING MEMBER
This invention relates to a novel fonn of material delivery device, for example, a medicament delivery device, such as an inhaler. In particular the invention provides a novel form of dry powder inhaler and a method of delivering a medicament.
Dry powder inhalers are known, such as CLICKHALER, produced by Innovata Biomed in the UK. Such a device is described in European Patent No 0 539 469.
Increasingly, patients are required to take more than one medicine and this is no less the case in the treatment of bronchial disorders. Thus, for example, combination therapies such as a steroid with a(32 agonist, e.g. fluticasone and salmeterol, have been commercially successful. To date, the administration of such combination therapies comprises the use of a predetermined formulation either as a dry powder, e.g. in a gelatin capsule, or an aerosol. However, this approach suffers from the disadvantage, inter alia, that the medical practitioner is restricted in that it is not possible to vary the quantities of the two medicaments administered. Thus, there has therefore been a long felt need for a dry powder inhalation system which permits the administration of combination therapies.
We have now developed a novel form of medicament delivery device that overcomes or mitigates this problem.
According to the invention we provide a delivery device which comprises a reservoir, a delivery passage for the delivery of material and a metering member characterised in that the delivery device is provided with a plurality of reservoirs and that the metering member is a frusto conical member provided with a plurality of measuring cups adapted to transfer one or more measured doses of material from one or more of the reservoirs to the delivery passage.
The device of the invention has utility in a variety of areas, including, for example, medicament delivery. Thus, it is especially suited as an inhaler and especially a dry powder inhaler (DPI).
It is within the scope of this invention for more than two medicaments to be administered, however, it is considered most likely that dual combination therapies would be preferred by the medical profession. Thus the description hereinafter will generally refer to a medicament delivery device adapted to administer a dual combination medicarnent, but it would be well understood by one skilled in the art that these references could be construed to multiple combinations.
Thus the medicament reservoir preferentially comprises a dual reservoir, the dual reservoir may, for example, comprise a pair of chimneys. Preferentially, each of the reservoirs is a bulk reservoir which supplies a plurality of doses measured by the metering member. The dimensions of the reservoirs may be the same or different depending, inter alia, upon the respective amounts of medicament it is intended to administer. It is important that the two reservoirs are isolated from one another in order to prevent cross contamination of one medicament with the other.
When the delivery device comprises an inhaler, it is preferentially a dry powder inhaler. An example of a conventional inhaler is a CLICKHALER (available from IB) which is provided with a single inhalation passage. However, in the combination therapy inhaler of the invention, the device may be provided with a single or with two inhalation passages.
Thus according to a preferred embodiment of the invention we provide an inhaler which comprises a medicament reservoir, an inhalation passage for the delivery of medicament and a metering member characterised in that the inhaler is provided with a plurality of inedicament reservoirs and the metering member is provided with a plurality of measuring cups adapted to transfer one or more measured doses of
2 ^
20-10-2001 GB00046.
medicament, from one or more of the medicament reservoirs to the inhalation passage.
In one embodiment of the present invention the metering member comprises a frusto conical member analogous to that described in European Patent No 0 539 469.
Thus, the metering member may comprise a frusto conical member wherein the side wall of the cone contains one or more measuring cups. Such a side wall can, preferably, include a plurality of spaced-apart measuring cups.
The use of the frusto-conical shape in the wall of the metering member containing the measuring cups allows a good seal to be obtained between the metering member and a seat against which the frusto-conical wall mates.
The metering member is adapted to transfer one or more measured doses of medicament from one or more of the medicament reservoirs to the delivery passage.
Therefore, the metering member is preferably provided with dual measuring cups or a series of dual measuring cups. As with the conventional CLICKHALER, since the metering member is substantially frusto conical in shape, the measuring cups are arranged along the outer surface of the side wall of the frusto conical member. Thus, the measuring cups may form two rows of cups around the outer surface of the metering member. The measuring cups in the rows may be aligned to form a plurality of columns of, e.g. two, measuring cups. Alternatively, the rows may be out of line so that the columns are staggered.
In a further alternative embodiment the metering member may comprise a first and second substantially frusto conical member each of which is provided with a single row of measuring cups. In a preferred embodiment the substantially frusto conical members are adjacent to one another and the rows of rimeasuring cups may be aligned or staggered as with the single frusto conical member device.
20-10-2001 GB00046.
medicament, from one or more of the medicament reservoirs to the inhalation passage.
In one embodiment of the present invention the metering member comprises a frusto conical member analogous to that described in European Patent No 0 539 469.
Thus, the metering member may comprise a frusto conical member wherein the side wall of the cone contains one or more measuring cups. Such a side wall can, preferably, include a plurality of spaced-apart measuring cups.
The use of the frusto-conical shape in the wall of the metering member containing the measuring cups allows a good seal to be obtained between the metering member and a seat against which the frusto-conical wall mates.
The metering member is adapted to transfer one or more measured doses of medicament from one or more of the medicament reservoirs to the delivery passage.
Therefore, the metering member is preferably provided with dual measuring cups or a series of dual measuring cups. As with the conventional CLICKHALER, since the metering member is substantially frusto conical in shape, the measuring cups are arranged along the outer surface of the side wall of the frusto conical member. Thus, the measuring cups may form two rows of cups around the outer surface of the metering member. The measuring cups in the rows may be aligned to form a plurality of columns of, e.g. two, measuring cups. Alternatively, the rows may be out of line so that the columns are staggered.
In a further alternative embodiment the metering member may comprise a first and second substantially frusto conical member each of which is provided with a single row of measuring cups. In a preferred embodiment the substantially frusto conical members are adjacent to one another and the rows of rimeasuring cups may be aligned or staggered as with the single frusto conical member device.
3 AMENDED SHEET
When the delivery device comprises separate metering members, it is preferable that they are both frusto conical members. In one embodiment the firusto conical metering members may optionally be positioned with the "closed" fivsto conical ends facing or alternatively, with the "open" ends facing.
As with the CLICKHALER described in the prior art patent, the frusto conical metering member is rotatable about a central axis. When the delivery device of the invention comprises two separate metering members then they will generally be aligned along the same axis. However, the axle about which they actually rotate may be the same, i.e. is a shared axle or they may be provided with separate axles.
The delivery device of the invention may be adapted so as to comprise a first, substantially conventional device, e.g. in the case of an inhaler, a CLICKHALER, which is provided with means to attach a second delivery device to it.
Preferably, the 15. second delivery will be a "clip on" device. Thus the first delivery device may be provided with means to receive a second delivery device. Although a number of means of attachment can be contemplated, one embodiment is for the first and second delivery devices to be provided with one or more tabs of, e.g. a resilient plastics material wherein the tab on the first delivery device is adapted to engage the tab on the second delivery device. Preferably each of the first and second delivery devices are provided with a plurality of tabs. In a further embodiment a conveiitional delivery device, e.g. an inhaler, may be provided with an adapter which is capable of engaging with a first and a second delivery device.
In the conventionally known CLICKHALER a medicament pocket is provided adjacent the measuring cup when the metering member is in the medicament delivery position. The medicament pocket forms a conduit between the measuring cup and the inhalation passage. Generally, the medicament pocket is aligned to be coplanar with the axis of rotation of the metering member. In the combination therapy inhaler of the invention, there are two medicament pockets provided. Thus, it is within the scope of this invention for the medicarnent pockets to be aligned coplanar with the
When the delivery device comprises separate metering members, it is preferable that they are both frusto conical members. In one embodiment the firusto conical metering members may optionally be positioned with the "closed" fivsto conical ends facing or alternatively, with the "open" ends facing.
As with the CLICKHALER described in the prior art patent, the frusto conical metering member is rotatable about a central axis. When the delivery device of the invention comprises two separate metering members then they will generally be aligned along the same axis. However, the axle about which they actually rotate may be the same, i.e. is a shared axle or they may be provided with separate axles.
The delivery device of the invention may be adapted so as to comprise a first, substantially conventional device, e.g. in the case of an inhaler, a CLICKHALER, which is provided with means to attach a second delivery device to it.
Preferably, the 15. second delivery will be a "clip on" device. Thus the first delivery device may be provided with means to receive a second delivery device. Although a number of means of attachment can be contemplated, one embodiment is for the first and second delivery devices to be provided with one or more tabs of, e.g. a resilient plastics material wherein the tab on the first delivery device is adapted to engage the tab on the second delivery device. Preferably each of the first and second delivery devices are provided with a plurality of tabs. In a further embodiment a conveiitional delivery device, e.g. an inhaler, may be provided with an adapter which is capable of engaging with a first and a second delivery device.
In the conventionally known CLICKHALER a medicament pocket is provided adjacent the measuring cup when the metering member is in the medicament delivery position. The medicament pocket forms a conduit between the measuring cup and the inhalation passage. Generally, the medicament pocket is aligned to be coplanar with the axis of rotation of the metering member. In the combination therapy inhaler of the invention, there are two medicament pockets provided. Thus, it is within the scope of this invention for the medicarnent pockets to be aligned coplanar with the
4 AMENDED SHEET
20-10-2001 GB00046,' axis of rotation of the metering member. However, a slimmer device is produced if the medicament pockets are aligned perpendicular to the axis of rotation.
Thus, in operation, the device may be moved to a first position in which the first medicament is transferred to a first measuring cup in the metering member. The device is then moved to a second position in which a second medicament is transferred from a second measuring cup. Then either separately or together the metering members are rotated to a third position where medicament is delivered to the delivery passage.
The dispensing member may be a conventionally known member such as a frusto conical member described herein and in EP 0 539 469 and may optionally be provided with a moisture resistant sleeve a.nd/or be provided with an air inlet. An air inlet is especially suited when the delivery device is an inhaler.
The delivery device of the invention is advantageous in that, inter alia, it may operate by the administration of a plurality of inedicaments at the same time, sequentially or at different times, e.g. a first medicament being administered in the morning and a second medicament in the afternoon.
A variety of medicaments may be administered by using the inhaler of the invention.
Such medicaments are generally antibiotics, bronchodilators or other anti-asthma drugs. Such medicaments include, but are not limited to 132-agonists, e.g.
fenoterol, formoterol, pirbuterol, reproterol, rimiterol, salbutamol, salmeterol and terbutaline;
non-selective beta-stimulants such as isoprenaline; xanthine bronchodilators, e.g.
theophylline, aminophylline and choline theophyllinate; anticholinergics, e.g.
ipratropium bromide; mast cell stabilisers, e.g. sodium cromoglycate and ketotifen;
bronchial anti-inflammatory agents, e.g. nedocromil sodium; and steroids, e.g.
beclomethasone dipropionate, fluticasone, budesonide and flunisolide; and combinations thereof.
20-10-2001 GB00046,' axis of rotation of the metering member. However, a slimmer device is produced if the medicament pockets are aligned perpendicular to the axis of rotation.
Thus, in operation, the device may be moved to a first position in which the first medicament is transferred to a first measuring cup in the metering member. The device is then moved to a second position in which a second medicament is transferred from a second measuring cup. Then either separately or together the metering members are rotated to a third position where medicament is delivered to the delivery passage.
The dispensing member may be a conventionally known member such as a frusto conical member described herein and in EP 0 539 469 and may optionally be provided with a moisture resistant sleeve a.nd/or be provided with an air inlet. An air inlet is especially suited when the delivery device is an inhaler.
The delivery device of the invention is advantageous in that, inter alia, it may operate by the administration of a plurality of inedicaments at the same time, sequentially or at different times, e.g. a first medicament being administered in the morning and a second medicament in the afternoon.
A variety of medicaments may be administered by using the inhaler of the invention.
Such medicaments are generally antibiotics, bronchodilators or other anti-asthma drugs. Such medicaments include, but are not limited to 132-agonists, e.g.
fenoterol, formoterol, pirbuterol, reproterol, rimiterol, salbutamol, salmeterol and terbutaline;
non-selective beta-stimulants such as isoprenaline; xanthine bronchodilators, e.g.
theophylline, aminophylline and choline theophyllinate; anticholinergics, e.g.
ipratropium bromide; mast cell stabilisers, e.g. sodium cromoglycate and ketotifen;
bronchial anti-inflammatory agents, e.g. nedocromil sodium; and steroids, e.g.
beclomethasone dipropionate, fluticasone, budesonide and flunisolide; and combinations thereof.
5 AMENDED SHEET
Specific combinations of medicaments which may be mentioned include combinations of steroids, such as, beclomethasone dipropionate, fluticasone, budesonide and flunisolide; and combinations of to 132-agonists, such as, formoterol and salmeterol. It is also within the scope of this invention to include combinations of one or more of the aforemeiitioned steroids with one or more of the aforementioned 132-agonists.
Further medicaments which may be mentioned include systemically active materials, such as, proteinaceous compounds and/or macromolecules, for example, hormones and mediators, such as insulin, human growth hormone, leuprolide and alpha interferon; growth factors, anticoagulants, immunomodulators, cytokines and nucleic acids.
By the term dry powder we mean a medicament in finely divided form.
The invention will now be described by way of example only and with reference to the accompanying drawings in which:
Figure 1 is a perspective view of a prior art inhaler;
Figure 2 is a partially cut away perspective view of a prior art inhaler;
Figure 3 is a schematic representation of the sequence of operation of a prior art inhaler;
Figure 4 is a perspective view of a prior art inhaler;
Figure 5 is a cross-sectional view of a prior art inhaler;
Figure 6 is a perspective view of an inhaler of the invention with two rows of measuring cups in a single frusto conical member;
Figure 7 is a cross-sectional view of the inhaler of Figure 6;
Figure 8 is a perspective view of an inhaler of the invention with two frusto conical members;
Figure 9 is a cross-sectional view of the inhaler of Figure 8;
Specific combinations of medicaments which may be mentioned include combinations of steroids, such as, beclomethasone dipropionate, fluticasone, budesonide and flunisolide; and combinations of to 132-agonists, such as, formoterol and salmeterol. It is also within the scope of this invention to include combinations of one or more of the aforemeiitioned steroids with one or more of the aforementioned 132-agonists.
Further medicaments which may be mentioned include systemically active materials, such as, proteinaceous compounds and/or macromolecules, for example, hormones and mediators, such as insulin, human growth hormone, leuprolide and alpha interferon; growth factors, anticoagulants, immunomodulators, cytokines and nucleic acids.
By the term dry powder we mean a medicament in finely divided form.
The invention will now be described by way of example only and with reference to the accompanying drawings in which:
Figure 1 is a perspective view of a prior art inhaler;
Figure 2 is a partially cut away perspective view of a prior art inhaler;
Figure 3 is a schematic representation of the sequence of operation of a prior art inhaler;
Figure 4 is a perspective view of a prior art inhaler;
Figure 5 is a cross-sectional view of a prior art inhaler;
Figure 6 is a perspective view of an inhaler of the invention with two rows of measuring cups in a single frusto conical member;
Figure 7 is a cross-sectional view of the inhaler of Figure 6;
Figure 8 is a perspective view of an inhaler of the invention with two frusto conical members;
Figure 9 is a cross-sectional view of the inhaler of Figure 8;
6 Figure 10 is a perspective view of an inhaler of the invention provided with medicament pockets aligned perpendicular to the axis of rotation of the metering member;
Figure 11 is a cross sectional view of an inhaler with the closed ends of the frusto conical metering members facing; and Figure 12 is a perspective view of a CLICKHALER provided with a "clip on"
combination attachment.
Referring to Figures 1 to 5, a dry powder inhaler (1) comprises a medicament reservoir (2), a medicament pocket (3) and a metering member (4). A medicament pocket (3) is connected to the medicament reservoir (2) by a reservoir support (5) and is itself connected to recess (6) which is provided with a back plate (7) forming a seat for the frusto conical metering member (4). The medicament pocket forms a conduit between the metering member (4) and the inhalation passage (not shown). The metering member (4) is rotatable about an axis (8). The metering member (4) is provided with a row of measuring cups (9) (also known as dispensing cups). The measuring cups (9) are dimensioned so as to measure a predetermined amount of medicament (10). In operation, medicament (10) is dispensed from the reservoir (2) into the measuring cup (9). The metering member is rotated (in an anti-clockwise direction) thus bringing the full measuring cup (11) into line with the medicament pocket (3). After inhalation of the medicament by the patient, the metering member (4) is further rotated to bring the measuring cup into the dump box (12) in an essentially inverted or upside down position allowing any residual medicament in the measuring cup (9) to be emptied into the dump box (12).
Referring now to Figures 6 and 7. A combination therapy inhaler (13) of the invention is provided with two medicament reservoirs (14 and 15) containing a first (16) and second (17) medicament. A metering member (18) comprises an essentially frusto conical member. The side wall (19) of the frusto conical member (18) is provided with two rows (20 and 21) of measuring cups (22). In the embodiment shown, the two rows (20 and 21) of measuring cups (22) are aligned so as to form
Figure 11 is a cross sectional view of an inhaler with the closed ends of the frusto conical metering members facing; and Figure 12 is a perspective view of a CLICKHALER provided with a "clip on"
combination attachment.
Referring to Figures 1 to 5, a dry powder inhaler (1) comprises a medicament reservoir (2), a medicament pocket (3) and a metering member (4). A medicament pocket (3) is connected to the medicament reservoir (2) by a reservoir support (5) and is itself connected to recess (6) which is provided with a back plate (7) forming a seat for the frusto conical metering member (4). The medicament pocket forms a conduit between the metering member (4) and the inhalation passage (not shown). The metering member (4) is rotatable about an axis (8). The metering member (4) is provided with a row of measuring cups (9) (also known as dispensing cups). The measuring cups (9) are dimensioned so as to measure a predetermined amount of medicament (10). In operation, medicament (10) is dispensed from the reservoir (2) into the measuring cup (9). The metering member is rotated (in an anti-clockwise direction) thus bringing the full measuring cup (11) into line with the medicament pocket (3). After inhalation of the medicament by the patient, the metering member (4) is further rotated to bring the measuring cup into the dump box (12) in an essentially inverted or upside down position allowing any residual medicament in the measuring cup (9) to be emptied into the dump box (12).
Referring now to Figures 6 and 7. A combination therapy inhaler (13) of the invention is provided with two medicament reservoirs (14 and 15) containing a first (16) and second (17) medicament. A metering member (18) comprises an essentially frusto conical member. The side wall (19) of the frusto conical member (18) is provided with two rows (20 and 21) of measuring cups (22). In the embodiment shown, the two rows (20 and 21) of measuring cups (22) are aligned so as to form
7 columns (23) of measuring cups (22a and 22b). In operation measuring cup (22a) is filled with a first medicament from reservoir (14) and measuring cup (22b) is fitted with a second medicament from reservoir (15). The metering member (18) is then rotated in an analogous fashion to the prior art device.
Referring to Figures 8 to 10. A first inhaler (24) resembles that of the prior art. A
second inhaler (25) also resembling that of the prior art is clipped onto the first to produce an inhaler (26) comprising two medicament reservoirs (27a and 27b) two metering members (28a and 28b) each provided with a single row of measuring cups (29a and 29b respectively) and two medicament pockets (30a and 30b). The metering members (28) operate in a similar fashion to the prior art. Metering member (28a) may be operated in conjunction with or independent of metering member (28b).
In Figure 10 the medicament pockets (30a and 30b) are arranged perpendicular to the axis of rotation of the metering members (28a and 28b) allowing a slimmer device to be produced.
Referring to Figure 11. An inhalation device is provided with two metering members (28a and 28b). The closed-ends (32 and 33) face each other.
A variety of mechanisms may be used for the operation of the inhaler. One preferred mechanism is for movement from the closed to the measuring position to be achieved by removal of a mouth piece which is operably linked to the moisture resistor.
Movement from the measuring position to the transitory position would use a mechanism similar to that described in EP 0 539 469, e.g. by depressing the button half way. Movement to the transfer position being achieved by further depressing the button, and then depression completely, moving the metering cone and the moisture resistor to the delivery position.
Referring to Figures 8 to 10. A first inhaler (24) resembles that of the prior art. A
second inhaler (25) also resembling that of the prior art is clipped onto the first to produce an inhaler (26) comprising two medicament reservoirs (27a and 27b) two metering members (28a and 28b) each provided with a single row of measuring cups (29a and 29b respectively) and two medicament pockets (30a and 30b). The metering members (28) operate in a similar fashion to the prior art. Metering member (28a) may be operated in conjunction with or independent of metering member (28b).
In Figure 10 the medicament pockets (30a and 30b) are arranged perpendicular to the axis of rotation of the metering members (28a and 28b) allowing a slimmer device to be produced.
Referring to Figure 11. An inhalation device is provided with two metering members (28a and 28b). The closed-ends (32 and 33) face each other.
A variety of mechanisms may be used for the operation of the inhaler. One preferred mechanism is for movement from the closed to the measuring position to be achieved by removal of a mouth piece which is operably linked to the moisture resistor.
Movement from the measuring position to the transitory position would use a mechanism similar to that described in EP 0 539 469, e.g. by depressing the button half way. Movement to the transfer position being achieved by further depressing the button, and then depression completely, moving the metering cone and the moisture resistor to the delivery position.
8 Referring to Figure 12. An inhalation device comprises a master system (34) comprising an actuator (35), a medicament reservoir (2) and a dosage counter (not shown). The device is provided with a secondary system (36) comprising its own medicament reservoir (37), an inhalation passagd (38) and a backplate (39).
The secondary system (6) is provided with a metering member (40) being a frusto conical member (41) with measuring cups (42). The metering member (40) is aligned coaxially with the metering member (4) of the master system. The metering member (4) is provided with an axial linking member (43). The linking member (43) sits on the axis of rotation (8) of metering member (4) and is adapted to drivably engage axially with metering member (40). Thus, in use, depression of the actuator (35) on the master system rotates both metering members (4 and 40) causing medicament to be dispensed from each medicament reservoir (2 and 37) into the respective measuring cups (9 and 42). The two medicaments, which may be the same or different, mix in the inhalation passage, before being inhaled by the patient.
The secondary system (6) is provided with a metering member (40) being a frusto conical member (41) with measuring cups (42). The metering member (40) is aligned coaxially with the metering member (4) of the master system. The metering member (4) is provided with an axial linking member (43). The linking member (43) sits on the axis of rotation (8) of metering member (4) and is adapted to drivably engage axially with metering member (40). Thus, in use, depression of the actuator (35) on the master system rotates both metering members (4 and 40) causing medicament to be dispensed from each medicament reservoir (2 and 37) into the respective measuring cups (9 and 42). The two medicaments, which may be the same or different, mix in the inhalation passage, before being inhaled by the patient.
9
Claims (29)
1. A delivery device which comprises a reservoir, a delivery passage for the delivery of material and a frusto conical metering member wherein the delivery device is provided with a plurality of reservoirs and that the metering member is provided with a plurality of measuring cups adapted to transfer a plurality of measured doses of material from a plurality of the reservoirs to the delivery passage.
2. A delivery device according to Claim 1 wherein the plurality of reservoirs comprises a dual reservoir.
3. A delivery device according to any one of Claims 1 to 2 wherein the plurality of reservoirs are bulk reservoirs.
4. A delivery device according to any one of Claims 1 to 3 wherein there are two delivery passages.
5. A delivery device according to any of Claims 1 to 4 wherein the material is a medicament.
6. A delivery device according to Claim 5 wherein the medicament is a dry powder.
7. A delivery device according to any one of Claims 1 to 5 wherein the device is an inhaler.
8. A delivery device according to Claim 7 wherein the inhaler is a dry powder inhaler.
9. An inhaler which comprises a medicament reservoir, an inhalation passage for the delivery of medicament and a metering member wherein the inhaler is provided with a plurality of medicament reservoirs and the metering member is provided with a plurality of measuring cups adapted to transfer a plurality of measured doses of medicament from a plurality of the medicament reservoirs to the inhalation passage.
10. An inhaler according to Claim 9, which comprises two inhalation passages.
11. A delivery device according to any one of Claims 1 to 10 wherein the metering member is provided with a dual set of measuring cups.
12. A delivery device according to any one of Claims 1 to 10 wherein the measuring cups form two rows of cups around the outer surface of the metering member.
13. A delivery device according to Claim 12 wherein the measuring cups in the rows are aligned to form columns each comprising two measuring cups.
14. A delivery device according to Claim 12 wherein the rows are out of line so that the columns are staggered.
15. A delivery device according to any one of Claims 1 to 10 wherein the metering member comprises a first and second substantially frusto conical member each of which is provided with a single row of measuring cups.
16. A delivery device according to Claim 15 wherein the substantially frusto conical members are adjacent to one another and the rows of measuring cups are aligned.
17. A delivery device according to Claim 16 wherein the substantially frusto conical members are adjacent to one another and the rows of measuring cups are staggered.
18. A delivery device according to Claim 15 wherein the frusto conical metering members are positioned with the "closed" frusto conical ends facing.
19. A delivery device according to Claim 15 wherein the "open" ends facing.
20. A delivery device according to any one of Claims 1 to 19 wherein metering member is rotatable about a central axis.
21. A delivery device according to Claim 15 wherein the first and second substantially frusto conical members are each rotatable about separate axles.
22. A delivery device according to any one of Claims 1 to 21 wherein the measuring cups are aligned coplanar with the axis of rotation of the metering member.
23. A delivery device according to any one of Claims 1 to 21 wherein the measuring cups are aligned perpendicular to the axis of rotation.
24. A delivery device according to any one of Claims 1 to 8 wherein the frusto conical member is provided with a moisture resistant sleeve.
25. A delivery device according to any one of Claims 1 to 24 wherein the measuring cups are each provided with an air inlet.
26. A delivery device according to any one of Claims 1 to 25 wherein the device is adapted to operate by the administration of a plurality of medicaments at the same time.
27. Use of a delivery device according to any one of Claims 1 to 26 adapted to administer a dry powder medicament.
28. Use according to Claims 27 wherein the delivery device is an inhaler.
29. Use of a delivery device according to any one of Claims 1 to 26 adapted to administer a combination of medicaments to a patient with a bronchial disorder.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9928265.9A GB9928265D0 (en) | 1999-12-01 | 1999-12-01 | Inhaler |
| GB9928265.9 | 1999-12-01 | ||
| PCT/GB2000/004623 WO2001039823A1 (en) | 1999-12-01 | 2000-12-01 | Inhaler |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2390791A1 CA2390791A1 (en) | 2001-06-07 |
| CA2390791C true CA2390791C (en) | 2009-02-03 |
Family
ID=10865413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002390791A Expired - Fee Related CA2390791C (en) | 1999-12-01 | 2000-12-01 | Material delivery device having a plurality of reservoirs and a frusto conical metering member |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6845772B2 (en) |
| EP (2) | EP1300171A3 (en) |
| JP (1) | JP4674027B2 (en) |
| AT (1) | ATE261326T1 (en) |
| AU (1) | AU782118B2 (en) |
| BR (1) | BR0016085A (en) |
| CA (1) | CA2390791C (en) |
| DE (1) | DE60008914T9 (en) |
| DK (1) | DK1233805T3 (en) |
| ES (1) | ES2217008T3 (en) |
| GB (1) | GB9928265D0 (en) |
| IL (2) | IL149623A0 (en) |
| MX (1) | MXPA02005279A (en) |
| NO (1) | NO332942B1 (en) |
| NZ (1) | NZ518827A (en) |
| PT (1) | PT1233805E (en) |
| WO (1) | WO2001039823A1 (en) |
| ZA (1) | ZA200203764B (en) |
Families Citing this family (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK285463B6 (en) * | 1998-01-30 | 2007-02-01 | Mibe Gmbh Arzneimittel | Inhalation apparatus for powder medications |
| FI108518B (en) * | 1999-04-23 | 2002-02-15 | Orion Yhtymae Oyj | Powder inhaler for combination medicine |
| FI107126B (en) * | 1999-04-23 | 2001-06-15 | Orion Yhtymae Oyj | Powder inhaler for combination medicine |
| ES2241611T3 (en) * | 1999-06-05 | 2005-11-01 | Innovata Biomed Limited | MEDICINES SUPPLY SYSTEM. |
| GB9920839D0 (en) | 1999-09-04 | 1999-11-10 | Innovata Biomed Ltd | Inhaler |
| DE19961300A1 (en) * | 1999-12-18 | 2001-06-21 | Asta Medica Ag | Storage system for medicinal products in powder form and inhaler equipped with them |
| US7103245B2 (en) | 2000-07-10 | 2006-09-05 | Massachusetts Institute Of Technology | High density integrated optical chip |
| PL365736A1 (en) * | 2001-02-06 | 2005-01-10 | Innovata Biomed Limited | Bimodal dry powder formulation for inhalation |
| GB0111337D0 (en) | 2001-05-10 | 2001-07-04 | Innovata Biomed Ltd | Device |
| FI20011317A0 (en) * | 2001-06-20 | 2001-06-20 | Orion Corp | The powder inhaler |
| US7931022B2 (en) | 2001-10-19 | 2011-04-26 | Respirks, Inc. | Method and apparatus for dispensing inhalator medicament |
| GB0128148D0 (en) * | 2001-11-23 | 2002-01-16 | Innovata Biomed Ltd | Assembly |
| US7258118B2 (en) | 2002-01-24 | 2007-08-21 | Sofotec Gmbh & Co, Kg | Pharmaceutical powder cartridge, and inhaler equipped with same |
| EP1467790A1 (en) * | 2002-01-25 | 2004-10-20 | Glaxo Group Limited | Medicament dispenser |
| GB0217199D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
| GB0201677D0 (en) * | 2002-01-25 | 2002-03-13 | Glaxo Group Ltd | Medicament dispenser |
| US6889690B2 (en) * | 2002-05-10 | 2005-05-10 | Oriel Therapeutics, Inc. | Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages |
| GB0217196D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
| GB0217198D0 (en) * | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
| EP1534367A1 (en) * | 2002-07-25 | 2005-06-01 | Glaxo Group Limited | Medicament dispenser |
| DE10300032B3 (en) * | 2003-01-03 | 2004-05-27 | E. Braun Gmbh | Inhaler for powdered medicament has pivoted inhalation tube which shuts off powder supply when in out-of-use position, and doses powder into airflow when in use |
| SE527191C2 (en) * | 2003-06-19 | 2006-01-17 | Microdrug Ag | Inhaler device and combined doses of tiotropium and fluticasone |
| SE527069C2 (en) * | 2003-06-19 | 2005-12-13 | Mederio Ag | Method and apparatus for administering drug powder |
| SE526850C2 (en) * | 2003-06-19 | 2005-11-08 | Microdrug Ag | Pharmaceutical combined dry powder dose separated on common dose bed |
| GB0317374D0 (en) | 2003-07-24 | 2003-08-27 | Glaxo Group Ltd | Medicament dispenser |
| US7451761B2 (en) * | 2003-10-27 | 2008-11-18 | Oriel Therapeutics, Inc. | Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances |
| US7377277B2 (en) * | 2003-10-27 | 2008-05-27 | Oriel Therapeutics, Inc. | Blister packages with frames and associated methods of fabricating dry powder drug containment systems |
| ITMO20040060A1 (en) * | 2004-03-18 | 2004-06-18 | Roberto Oliva | INHALER FOR POWDER PREPARATIONS |
| WO2005102429A1 (en) | 2004-04-21 | 2005-11-03 | Innovata Biomed Limited | Inhaler |
| GB0409197D0 (en) | 2004-04-24 | 2004-05-26 | Innovata Biomed Ltd | Device |
| GB0418278D0 (en) | 2004-08-16 | 2004-09-15 | Glaxo Group Ltd | Medicament dispenser |
| US8210171B2 (en) * | 2004-09-13 | 2012-07-03 | Oriel Therapeutics, Inc. | Tubular dry powder drug containment systems, associated inhalers and methods |
| GB0427858D0 (en) * | 2004-12-20 | 2005-01-19 | Glaxo Group Ltd | Manifold for use in medicament dispenser |
| GB0427853D0 (en) * | 2004-12-20 | 2005-01-19 | Glaxo Group Ltd | Manifold for use in medicament dispenser |
| CN101175523B (en) * | 2005-05-10 | 2011-01-19 | 邦-奥鲁夫森医用公司 | Forward metering valve |
| GB0515584D0 (en) | 2005-07-28 | 2005-09-07 | Glaxo Group Ltd | Medicament dispenser |
| DE102005046645B3 (en) * | 2005-09-29 | 2006-07-20 | Braunform Gmbh | Medical powder inhaler has at least two reservoir containers from which different powders can be separately forwarded into a metering unit so that they are mixed together when traveling along an inhalation tube |
| AR058290A1 (en) * | 2005-12-12 | 2008-01-30 | Glaxo Group Ltd | MEDICINAL DISPENSER |
| AR058289A1 (en) * | 2005-12-12 | 2008-01-30 | Glaxo Group Ltd | COLLECTOR TO BE USED IN MEDICINAL DISPENSER |
| US7832395B2 (en) * | 2006-03-09 | 2010-11-16 | Oxygen Plus, Inc. | Portable oxygen delivery apparatus |
| CN101489613A (en) * | 2006-07-14 | 2009-07-22 | 阿斯利康(瑞典)有限公司 | Inhalation system and delivery device for the administration of a drug in the form of dry powder |
| GB0622827D0 (en) | 2006-11-15 | 2006-12-27 | Glaxo Group Ltd | Sheet driver for use in a drug dispenser |
| DE102007017725A1 (en) * | 2007-04-16 | 2008-10-23 | Astrazeneca Ab | Inhaler for powdered substances |
| EP2058025B1 (en) * | 2007-11-09 | 2014-09-03 | Hitachi Ltd. | Powder medicine administering apparatus |
| US8790366B2 (en) * | 2007-11-13 | 2014-07-29 | Alcon Research, Ltd. | Fan-shaped cannula for sealing ophthalmic incisions |
| EP2230934B8 (en) | 2007-12-14 | 2012-10-24 | AeroDesigns, Inc | Delivering aerosolizable food products |
| GB0800459D0 (en) * | 2008-01-11 | 2008-02-20 | Innovata Biomed Ltd | Improvements in or relating to inhalers |
| GB0800457D0 (en) * | 2008-01-11 | 2008-02-20 | Innovata Biomed Ltd | Improvements in or relating to inhalers |
| GB0912373D0 (en) * | 2009-07-16 | 2009-08-26 | Innovata Biomed Ltd | Improvements in or relating to dry powder inhalers |
| CA2780138A1 (en) | 2009-11-24 | 2011-06-03 | Gilead Sciences, Inc. | Inhaled fosfomycin/tobramycin for the treatment of chronic obstructive pulmonary disease |
| WO2011081937A1 (en) | 2009-12-15 | 2011-07-07 | Gilead Sciences, Inc. | Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy |
| ES2666676T3 (en) * | 2009-12-26 | 2018-05-07 | Inspiro Medical Ltd | Dry Powder Management Device |
| UY33372A (en) | 2010-05-10 | 2011-12-30 | Gilead Sciences Inc | ? QUINOLINA BI? FUNCTIONAL ANALOGS, ITS USE IN THE MANUFACTURE OF MEDICINES, COMPOSITIONS THAT UNDERSTAND AND PREPARATION PROCESSES ?. |
| WO2011143106A1 (en) | 2010-05-10 | 2011-11-17 | Gilead Sciences, Inc. | Bi - functional pyrazolopyridine compounds |
| WO2012154483A1 (en) | 2011-05-06 | 2012-11-15 | Gilead Sciences, Inc. | Dry powder fosfomycin/tobramycin formulation for inhalation |
| AR086745A1 (en) | 2011-06-27 | 2014-01-22 | Parion Sciences Inc | 3,5-DIAMINO-6-CHLORINE-N- (N- (4- (4- (2- (HEXIL (2,3,4,5,6-PENTAHYDROXIHEXIL)) AMINO) ETOXI) PHENYL) BUTIL) CARBAMIMIDOIL) PIRAZINA -2-CARBOXAMIDE |
| GB2498746A (en) | 2012-01-26 | 2013-07-31 | Innovata Biomed Ltd | Inhaler which locks when empty |
| WO2013114371A1 (en) | 2012-02-01 | 2013-08-08 | Protalix Ltd. | Dry powder formulations of dnase i |
| GB2499597A (en) | 2012-02-21 | 2013-08-28 | Innovata Biomed Ltd | Dry powder inhaler with stepped rotation of metering member |
| KR102109223B1 (en) | 2012-05-29 | 2020-05-11 | 패리온 사이언스 인코퍼레이티드 | Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases |
| PE20151054A1 (en) | 2012-12-17 | 2015-08-07 | Parion Sciences Inc | CHLORINE-PIRAZINE CARBOXAMIDE DERIVATIVES WITH BLOCKING ACTIVITY ON THE EPITHELIAL SODIUM CHANNELS |
| CA2896686A1 (en) | 2012-12-17 | 2014-06-26 | Parion Sciences, Inc. | 3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds |
| RU2018138195A (en) | 2012-12-17 | 2018-12-18 | Пэрион Сайенсиз, Инк. | COMPOUNDS 3,5-DIAMINO-6-CHLORO-N- (N- (4-Phenylbutyl) Carbamimidoyl) Pyrazine-2-Carboxamide |
| DE102014005647B4 (en) * | 2014-01-30 | 2016-05-12 | Klaus-Dieter Beller | Powder inhaler and powder inhaler set |
| DE102014005646B4 (en) * | 2014-01-30 | 2016-05-12 | Klaus-Dieter Beller | Powder inhaler and powder inhalation kit |
| SE538400C2 (en) * | 2014-04-03 | 2016-06-14 | Iconovo Ab | Dry powder inhaler |
| WO2016057693A1 (en) | 2014-10-10 | 2016-04-14 | Alnylam Pharmaceuticals, Inc. | Methods and compositions for inhalation delivery of conjugated oligonucleotide |
| USD767112S1 (en) * | 2015-04-15 | 2016-09-20 | K&N Engineering, Inc. | Vent breather |
| KR200482260Y1 (en) * | 2015-05-22 | 2017-01-04 | 동국대학교 산학협력단 | Container for selectively exhausting medicine |
| GB202004831D0 (en) * | 2020-04-01 | 2020-05-13 | Ondosis Ab | Delivery device for oral dosage forms |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2346730C3 (en) | 1973-09-17 | 1980-10-16 | Carl Heyer Gmbh, Inhalationstechnik, 5427 Bad Ems | Device for aerosol treatment of people, animals, objects, substances and the like in a treatment room |
| US5007419A (en) * | 1989-09-25 | 1991-04-16 | Allan Weinstein | Inhaler device |
| US5002048A (en) * | 1989-12-12 | 1991-03-26 | Makiej Jr Walter J | Inhalation device utilizing two or more aerosol containers |
| GB9015522D0 (en) * | 1990-07-13 | 1990-08-29 | Braithwaite Philip W | Inhaler |
| GB9026025D0 (en) * | 1990-11-29 | 1991-01-16 | Boehringer Ingelheim Kg | Inhalation device |
| GB9203761D0 (en) * | 1992-02-21 | 1992-04-08 | Innovata Biomed Ltd | Inhaler |
| US5437267A (en) * | 1993-08-03 | 1995-08-01 | Weinstein; Allan | Device for delivering aerosol to the nasal membranes and method of use |
| US5524613A (en) * | 1993-08-25 | 1996-06-11 | Habley Medical Technology Corporation | Controlled multi-pharmaceutical inhaler |
| US5664557A (en) * | 1994-03-10 | 1997-09-09 | Respiratory Delivery Systems, Inc. | Releasably engageable coupling for an inhaler |
| DE19523516C1 (en) * | 1995-06-30 | 1996-10-31 | Asta Medica Ag | Inhaler for administering medication from blister packs |
| US6234167B1 (en) * | 1998-10-14 | 2001-05-22 | Chrysalis Technologies, Incorporated | Aerosol generator and methods of making and using an aerosol generator |
| US6196218B1 (en) * | 1999-02-24 | 2001-03-06 | Ponwell Enterprises Ltd | Piezo inhaler |
| FI108518B (en) * | 1999-04-23 | 2002-02-15 | Orion Yhtymae Oyj | Powder inhaler for combination medicine |
| US6543443B1 (en) * | 2000-07-12 | 2003-04-08 | Aerogen, Inc. | Methods and devices for nebulizing fluids |
| US6523536B2 (en) * | 2001-03-12 | 2003-02-25 | Birdsong Medical Devices, Inc. | Dual-canister inhaler having a spacer and easy to operate lever mechanism |
| US7931022B2 (en) * | 2001-10-19 | 2011-04-26 | Respirks, Inc. | Method and apparatus for dispensing inhalator medicament |
-
1999
- 1999-12-01 GB GBGB9928265.9A patent/GB9928265D0/en not_active Ceased
-
2000
- 2000-12-01 IL IL14962300A patent/IL149623A0/en active IP Right Grant
- 2000-12-01 MX MXPA02005279A patent/MXPA02005279A/en active IP Right Grant
- 2000-12-01 AT AT00985459T patent/ATE261326T1/en active
- 2000-12-01 EP EP03075040A patent/EP1300171A3/en not_active Withdrawn
- 2000-12-01 CA CA002390791A patent/CA2390791C/en not_active Expired - Fee Related
- 2000-12-01 PT PT00985459T patent/PT1233805E/en unknown
- 2000-12-01 US US10/148,288 patent/US6845772B2/en not_active Expired - Fee Related
- 2000-12-01 NZ NZ518827A patent/NZ518827A/en not_active IP Right Cessation
- 2000-12-01 JP JP2001541553A patent/JP4674027B2/en not_active Expired - Fee Related
- 2000-12-01 BR BR0016085-7A patent/BR0016085A/en not_active IP Right Cessation
- 2000-12-01 ES ES00985459T patent/ES2217008T3/en not_active Expired - Lifetime
- 2000-12-01 EP EP00985459A patent/EP1233805B1/en not_active Expired - Lifetime
- 2000-12-01 WO PCT/GB2000/004623 patent/WO2001039823A1/en active IP Right Grant
- 2000-12-01 DE DE60008914T patent/DE60008914T9/en active Active
- 2000-12-01 DK DK00985459T patent/DK1233805T3/en active
- 2000-12-01 AU AU21878/01A patent/AU782118B2/en not_active Ceased
-
2002
- 2002-05-10 ZA ZA200203764A patent/ZA200203764B/en unknown
- 2002-05-13 IL IL149623A patent/IL149623A/en not_active IP Right Cessation
- 2002-05-29 NO NO20022545A patent/NO332942B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1300171A2 (en) | 2003-04-09 |
| JP4674027B2 (en) | 2011-04-20 |
| BR0016085A (en) | 2002-08-06 |
| AU2187801A (en) | 2001-06-12 |
| EP1233805B1 (en) | 2004-03-10 |
| ES2217008T3 (en) | 2004-11-01 |
| NO332942B1 (en) | 2013-02-04 |
| IL149623A (en) | 2007-07-24 |
| ATE261326T1 (en) | 2004-03-15 |
| WO2001039823A1 (en) | 2001-06-07 |
| IL149623A0 (en) | 2002-11-10 |
| AU782118B2 (en) | 2005-07-07 |
| US6845772B2 (en) | 2005-01-25 |
| NZ518827A (en) | 2005-06-24 |
| DE60008914T2 (en) | 2005-03-10 |
| NO20022545D0 (en) | 2002-05-29 |
| DE60008914D1 (en) | 2004-04-15 |
| PT1233805E (en) | 2004-07-30 |
| ZA200203764B (en) | 2004-01-28 |
| US20030116157A1 (en) | 2003-06-26 |
| DE60008914T9 (en) | 2005-06-23 |
| JP2003515396A (en) | 2003-05-07 |
| CA2390791A1 (en) | 2001-06-07 |
| EP1233805A1 (en) | 2002-08-28 |
| DK1233805T3 (en) | 2004-07-12 |
| MXPA02005279A (en) | 2003-09-22 |
| EP1300171A3 (en) | 2003-08-13 |
| NO20022545L (en) | 2002-05-29 |
| GB9928265D0 (en) | 2000-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2390791C (en) | Material delivery device having a plurality of reservoirs and a frusto conical metering member | |
| US7571723B2 (en) | Delivery device | |
| AU773205B2 (en) | Storage system for medicaments in powder form and inhaler provided therewith | |
| EP1183061B2 (en) | Medicament delivery system | |
| AU760750B2 (en) | Powder inhaler for combined medicament | |
| WO2002089882A1 (en) | Gauge | |
| ZA200109579B (en) | Delivery system. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20161201 |